ISD-IMMUNOTECH
ISD-Immunotech develops a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients.
ISD-IMMUNOTECH
Social Links:
Industry:
Biotechnology Health Care Information Technology Medical
Founded:
2013-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.isd-immunotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.isd-immunotech.com Semrush global rank: 5.49 M Semrush visits lastest month: 1.56 K
Unable to get host informations!!!
More informations about "ISD-Immunotech"
ISD Immunotech - Aarhus University
Jul 1, 2025 ISD Immunotech is developing a first-in-class peptide therapeutic to treat severe forms of systemic lupus erythematosus (SLE or Lupus) and other serious autoimmune …See details»
ISD-Immunotech - Crunchbase Company Profile & Funding
ISD-Immunotech is funded by Novo Holdings. When was the last funding round for ISD-Immunotech? ISD-Immunotech closed its last funding round on Jul 1, 2020 from a Venture - …See details»
iSD Immunotech - 2025 Company Profile & Team - Tracxn
ISD Immunotech is a series A company based in Aarhus (Denmark), founded in 2007 by Claus Hansen and Lars Jorgen Ostergaard. It operates as a Developer of immunoregulatory peptide …See details»
ISD-Immunotech 2025 Company Profile: Valuation, Funding
ISD-Immunotech was founded in 2007. Where is ISD-Immunotech headquartered? ISD-Immunotech is headquartered in Vejle, Denmark. What is the size of ISD-Immunotech? ISD …See details»
ISD Immunotech, a Novo Seeds Portfolio Company, Enters …
Nov 23, 2020 ISD Immunotech is a private preclinical biotech startup focusing on the development of a peptide therapeutic, ISD-017, which uniquely blocks all aspects of STING …See details»
iSD Immunotech - Kopenhagen, Denmark - bionity.com
May 14, 2019 iSD Immunotech is a spin-out of Aarhus University, Denmark and is dedicated to developing the first efficacious treatment - a targeted molecular therapy for the most severe …See details»
ISD-Immunotech - Headquarter Location, Corporate Office …
ISD-Immunotech is Biotechnology in Denmark that focus on cytokines which business. Founded in 2013. They cover business area such as developer, sting modulator, severe systemic lupus …See details»
ISD-Immunotech - LinkedIn
ISD Immunotech is developing STING modulators to treat severe Systemic lupus erythematosus (SLE) or Lupus by targeting the STING pathway. SLE is a complex and devastating …See details»
iSD Immunotech ApS - Company Profile and News - Bloomberg …
Company profile page for iSD Immunotech ApS including stock price, company news, executives, board members, and contact informationSee details»
ISD Immunotech | CipherBio
Explore ISD Immunotech's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
ISD Immunotech ApS | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
ISD Immunotech, a Novo Seeds portfolio company, enters …
Nov 23, 2020 ISD Immunotech is a private preclinical biotech startup focusing on the development of a peptide therapeutic, ISD-017, which uniquely blocks all aspects of STING …See details»
ISD Immunotech (company) - Nordic 9
ISD Immunotech (private company) isd-immunotech.com . See something wrong or missing? Let us know. Offices: Aarhus. Industry: Biotech Health services. Business model: B2B. ISD …See details»
ISD Immunotech strengthens its scientific advisory board
Sep 20, 2021 ”ISD Immunotech is an innovative new start-up on the Danish biotech scene. The company is led by a passionate and dedicated management team, board and SAB that has a …See details»
ISD Immunotech - Products, Competitors, Financials, Employees ...
ISD-Immunotech develops a therapy to treat severe Systemic lupus erythematosus (SLE) patients. Use the CB Insights Platform to explore ISD Immunotech's full profile. ISD …See details»
ISD-Immunotech - Funding, Financials, Valuation & Investors
Jul 1, 2020 ISD-Immunotech develops a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients. New. Resources. Advanced Search. ... How much …See details»
ISD Immunotech, a Novo Seeds Portfolio Company, Enters …
Nov 23, 2020 Copenhagen-based ISD Immunotech (ISD), a Novo Seeds Portfolio Company, today announced a strategic research collaboration with Cambridge, MA-based Biogen …See details»
ISD Immunotech enters strategic research collaboration
Mar 8, 2021 ISD and Biogen will work together to develop ISD’s lead compound, ISD 017, which is being developed to treat severe lupus – systemic lupus erythematosus (SLE). ISD 017 is a …See details»
ISD-Immunotech - Contacts, Employees, Board Members
ISD-Immunotech has 2 current employee profiles, including CFO & Co-founder Claus Hansen. Claus Hansen CFO & Co-founder. Jeroen Bakker Chief Business Officer. Board Member and …See details»
ISD-Immunotech - Updates, News, Events, Signals & Triggers
ISD-Immunotech develops a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»